Insider Trading History of Atp Iii Gp, Ltd.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Atp Iii Gp, Ltd. since 2019. The trader's CIK number is 1593453. At the time of the last reporting, Atp Iii Gp, Ltd. was the 10% Owner of Stoke Therapeutics, Inc.. (stock ticker symbol STOK). Also see all insider trading activities at Stoke Therapeutics, Inc..

Note that in the past ATP III GP, Ltd. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Stoke Therapeutics, Inc. (STOK) by Atp Iii Gp, Ltd.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 STOK 375,000 $14,625,000 0 $0 0 $0
2019 STOK 1,388,889 $25,000,002 0 $0 0 $0

Yearly summary of insider trading at Akero Therapeutics, Inc. (AKRO) by Atp Iii Gp, Ltd.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 AKRO 415,000 $14,940,000 0 $0 0 $0
2019 AKRO 900,000 $14,400,000 0 $0 0 $0


Insider trading activities at 2 companies by Atp Iii Gp, Ltd.:

1. Stoke Therapeutics, Inc. (STOK)

2. Akero Therapeutics, Inc. (AKRO)

Table 1. Insider trading of Stoke Therapeutics, Inc. (STOK) by Atp Iii Gp, Ltd.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-11-24 STOK Buy 375,000 39.00 14,625,000
2019-06-21 STOK Buy 1,388,889 18.00 25,000,002

Table 2. Insider trading of Akero Therapeutics, Inc. (AKRO) by Atp Iii Gp, Ltd.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-07-10 AKRO Buy 415,000 36.00 14,940,000
2019-06-24 AKRO Buy 900,000 16.00 14,400,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Atp Iii Gp, Ltd. (10% Owner of Stoke Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.